Dr. Andreas Schmidt

Dr. Andreas Schmidt is a serial entrepreneur turned international investor. He as has built deep tech startups in Asia, Europe, and the US. After selling his last company Proteona to Singleron Biotechnologies, he has been heading their global business development, applying single cell technologies to precision medicine. Andreas has formed several consortia for multi-center clinical trials and pharma partnerships in cell and gene therapy based on single cell and AI-driven technologies. Andreas Schmidt is involved in multiple startups and investment institutions as board member, mentor, and shareholder. He is a Berkeley trained immunologist and was one of the early entrepreneurs of the in Singapore-MIT Alliance of Research and Technology (SMART).